CHINA PHARMA HOLDINGS, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of $1.44 million for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-12-28.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2015-12-28
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2015-06-30 was $1.44M.
- CHINA PHARMA HOLDINGS, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2014-06-30 was -$8.53M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month |
|---|---|---|
| 2015-06-30 | $1.44M 10-Q · filed 2015-12-28 | -$6.23M 10-Q · filed 2015-12-28 |
| 2014-06-30 | -$8.53M 10-Q · filed 2015-12-28 | -$10.86M 10-Q · filed 2015-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |